Design of Antimicrobial Peptides: Progress Made with Human Cathelicidin LL-37

Designing effective antimicrobial peptides based on the natural LL-37 template represents one of the most promising approaches to combating drug-resistant infections. This review by Wang, Narayana, Mishra, and colleagues documented the major progress made in engineering LL-37-derived antimicrobial peptides with enhanced therapeutic properties.

The authors examined the various modification strategies that have been applied to LL-37, including amino acid substitutions, truncations, and structural modifications designed to improve antimicrobial potency, stability, and selectivity. The review covered both rational design approaches and high-throughput screening methods used to optimize peptide candidates.

The review highlighted numerous successful modifications that significantly enhance LL-37's therapeutic potency against resistant pathogens. These engineered variants demonstrated improved killing activity, better stability in biological fluids, and enhanced selectivity for microbial over mammalian cells, addressing key challenges in antimicrobial peptide development.

The progress documented in this review brings LL-37-based therapies closer to clinical application. For the broader field of peptide therapeutics, these advances demonstrate that nature's antimicrobial peptides can serve as powerful templates for designing next-generation anti-infective agents that overcome the limitations of conventional antibiotics.